by ZPHC
Semaglutide 10mg kit (5×2mg) by ZPHC. Best-value GLP-1 research kit.
In stock
Pay with Bitcoin or USDT (TRC-20) on this site, or contact a representative for a card or bank payment link. Free EU shipping over €250.
Batch certificate of analysis available on request via Telegram or the contact form.
ZPHC Semaglutide 10mg kit (5×2mg vials) delivers five 2mg lyophilized vials — double the dose per vial versus the 5mg kit — for extended GLP-1 receptor research protocols. Semaglutide activates GLP-1 receptors in the hypothalamus, pancreas and GI tract, producing appetite suppression, enhanced satiety signalling and improved glycaemic control. STEP programme Phase 3 trials documented 15–17% weight reduction over 68 weeks.
The 5×2mg format is the most cost-efficient semaglutide option in the ZPHC range. EU stock, ZPHC GMP-grade production, Janoshik-verified 99%+ purity. For laboratory research use only.
Weight Loss & GLP-1
The top 10 most-researched peptides of 2025 ranked by published study volume, mechanistic depth, and research versatility. Covering BPC-157, TB-500, semaglutide, ipamorelin, SS-31, retatrutide, PT-141, CJC-1295, tirzepatide, and NAD+ precursor peptides with their current research status.
6 min read
Peptides & Recovery
Semaglutide-based metabolic research protocols use diet-induced obesity (DIO) rodent models to study GLP-1R-mediated weight loss, glycemic improvement, and lipid remodeling. Guide to the semaglutide DIO research stack — compound selection, protocol design, dose escalation, and endpoints.
4 min read
Peptides & Recovery
Semaglutide is a complex acylated GLP-1 analog requiring HPLC-MS identity verification and high purity COA for legitimate research use. Guide for European researchers on semaglutide quality requirements, EU supply advantages, and what distinguishes research-grade semaglutide from substandard supply.
3 min read
Research use only. All products are sold strictly for in-vitro and laboratory research. Not for human consumption, veterinary use, diagnosis, treatment or prevention of any disease. Must be handled by qualified professionals in a controlled laboratory setting. JuicedPharma makes no therapeutic or medical claims about this compound.
Hilma Biocare
GLP-1 receptor agonist. The active compound in Ozempic/Wegovy research.
99.0%· Janoshik
Hilma Biocare
Pre-filled semaglutide pen. Convenient auto-injector for research use.
99.0%· Janoshik
Pharmacom Labs
Pharmacom T3 liothyronine. 50mcg double-strength tablets.
99%+· Pharmacom
Pharmacom Labs
Sibutramine 15mg double-strength tablets. Central appetite research.
99%+· Pharmacom
Resellers, laboratories and publishers: apply for partner pricing, volume terms and a dedicated representative.
Research use only. All products are sold strictly for in-vitro and laboratory research. Not for human consumption, veterinary use, diagnosis, treatment or prevention of any disease. Products sold by JuicedPharma are not medicines. By ordering you confirm you are a qualified person buying for research in compliance with applicable regulations. Full disclaimer